中国医药科学
中國醫藥科學
중국의약과학
CHINA MEDICINE AND PHARMACY
2015年
6期
171-172,175
,共3页
徐伟%李原学%蔡广育%梁昕
徐偉%李原學%蔡廣育%樑昕
서위%리원학%채엄육%량흔
经尿道输尿管镜碎石%微创经皮肾碎石%输尿管上段结石
經尿道輸尿管鏡碎石%微創經皮腎碎石%輸尿管上段結石
경뇨도수뇨관경쇄석%미창경피신쇄석%수뇨관상단결석
Transurethral ureteroscopy lithotripsy%Minimally invasive percutaneous nephrolithotomy gravel%Upper ureteral calculi
目的:比较经尿道输尿管镜碎石与微创经皮肾碎石治疗输尿管上段结石的治疗效果。方法选取我院2010年1月~2013年12月收治的112例输尿管上段结石患者为研究对象,将患者随机分为两组,A组52例采用经尿道输尿管镜碎石治疗,B组采用微创经皮肾碎石治疗,比较两组结石清除率、治疗成功率与术后并发症发生率。结果两组在治疗效果与并发症发生率上比较差异显著,具有统计学意义(P<0.05)。结论在输尿管上段结石治疗中,采用微创经皮肾碎石术治疗时效果显著,术后并发症发生率较低,值得在临床中推广。
目的:比較經尿道輸尿管鏡碎石與微創經皮腎碎石治療輸尿管上段結石的治療效果。方法選取我院2010年1月~2013年12月收治的112例輸尿管上段結石患者為研究對象,將患者隨機分為兩組,A組52例採用經尿道輸尿管鏡碎石治療,B組採用微創經皮腎碎石治療,比較兩組結石清除率、治療成功率與術後併髮癥髮生率。結果兩組在治療效果與併髮癥髮生率上比較差異顯著,具有統計學意義(P<0.05)。結論在輸尿管上段結石治療中,採用微創經皮腎碎石術治療時效果顯著,術後併髮癥髮生率較低,值得在臨床中推廣。
목적:비교경뇨도수뇨관경쇄석여미창경피신쇄석치료수뇨관상단결석적치료효과。방법선취아원2010년1월~2013년12월수치적112례수뇨관상단결석환자위연구대상,장환자수궤분위량조,A조52례채용경뇨도수뇨관경쇄석치료,B조채용미창경피신쇄석치료,비교량조결석청제솔、치료성공솔여술후병발증발생솔。결과량조재치료효과여병발증발생솔상비교차이현저,구유통계학의의(P<0.05)。결론재수뇨관상단결석치료중,채용미창경피신쇄석술치료시효과현저,술후병발증발생솔교저,치득재림상중추엄。
Objective To compare the therapeutic effect of transurethral lithotripsy and ureteroscopy minimally invasive percutaneous nephrolithotomy lithotripsy in upper ureteral calculi treatment. Methods 112 cases patients with ureteral stones treated in our hospital from January 2010 to December 2013 were selected as research object, the patients were randomly divided into two groups, 52 cases in A group received transurethral ureteroscopy lithotripsy, group B received minimally invasive percutaneous nephrolithotomy lithotripsy, stone clearance rate, treatment success rate and incidence of postoperative complications were compared. Result The treatment effect and complication rates between the two groups were significantly different, with statistical significance (P<0.05). Conclusion In the treatment of upper ureteral calculi, treatment effect using minimally invasive percutaneous nephrolithotomy lithotripsy was significantly, lower incidence of postoperative complications, should be promoted in clinical.